Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Rapid Micro Biosystems, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q4 2023
- Shares held
- 19.1M
- −1.04M (−5.2%) vs. Q4 2023
- Total value
- $18.2M
- +$3.37M (+22.7%) vs. Q4 2023
- New holders
- 1
- 5 more added
- Sold out
- 4
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $8.18M | 0.66% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $4.79M | 20.73% | 00.0% | Unchanged |
| Glenview Capital Management, LLC | 1,318,288 | $1.28M | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 1,019,728 | $989.1K | 0.00% | −1,729−0.2% | Reduced |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $768.3K | 1.85% | 00.0% | Unchanged |
| Vanguard Group Inc | 728,484 | $706.6K | 0.00% | +1100.0% | Added |
| JPMorgan Chase & Co | 622,831 | $604.1K | 0.00% | −128,481−17.1% | Reduced |
| Advent International Corp | 577,777 | $560.4K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 161,153 | $156.4K | 0.00% | +5,889+3.8% | Added |
| Millennium Management LLC | 66,187 | $64.2K | 0.00% | +49,012+285.4% | Added |
| Renaissance Technologies LLC | 57,387 | $56.0K | 0.00% | −20,500−26.3% | Reduced |
| State Street Corp | 26,074 | $25.3K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,639 | $18.1K | 0.00% | −199,648−91.5% | Reduced |
| Northern Trust Corp | 15,650 | $15.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,880 | $11.0K | 0.00% | −5,184−32.3% | Reduced |
| Morgan Stanley | 10,108 | $9.80K | 0.00% | −536−5.0% | Reduced |
| Tower Research Capital LLC (TRC) | 5,547 | $5.38K | 0.00% | −4,260−43.4% | Reduced |
| UBS Group AG | 246 | $239 | 0.00% | +246 | New |
| Wells Fargo & Company | 157 | $152 | 0.00% | +3+1.9% | Added |
| Bank of America Corp | 83 | $81 | 0.00% | +69+492.9% | Added |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | 00.0% | Unchanged |
| Resources Management Corp | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 60 | $0 | 0.00% | −190−76.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,135−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,463−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |